170 related articles for article (PubMed ID: 24981059)
1. Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure.
Dai C; Wang H; Sung SS; Sharma R; Kannapell C; Han W; Wang Q; Davidson A; Gaskin F; Fu SM
Clin Immunol; 2014 Sep; 154(1):66-71. PubMed ID: 24981059
[TBL] [Abstract][Full Text] [Related]
2. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis.
Ge Y; Jiang C; Sung SS; Bagavant H; Dai C; Wang H; Kannapell CC; Cathro HP; Gaskin F; Fu SM
J Exp Med; 2013 Oct; 210(11):2387-401. PubMed ID: 24101379
[TBL] [Abstract][Full Text] [Related]
3. A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus.
Chowdhary VR; Dai C; Tilahun AY; Hanson JA; Smart MK; Grande JP; Rajagopalan G; Fu SM; David CS
J Immunol; 2015 Nov; 195(10):4660-7. PubMed ID: 26475924
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
5. Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes.
Bagavant H; Deshmukh US; Wang H; Ly T; Fu SM
J Immunol; 2006 Dec; 177(11):8258-65. PubMed ID: 17114504
[TBL] [Abstract][Full Text] [Related]
6. Genetic approach to study lupus glomerulonephritis.
Ge Y; Brown MG; Wang H; Fu SM
Methods Mol Biol; 2012; 900():271-90. PubMed ID: 22933074
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation.
Ramanujam M; Kahn P; Huang W; Tao H; Madaio MP; Factor SM; Davidson A
Arthritis Rheum; 2009 Apr; 60(4):1096-101. PubMed ID: 19333924
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha in systemic lupus erythematosus.
Crow MK; Kirou KA
Curr Opin Rheumatol; 2004 Sep; 16(5):541-7. PubMed ID: 15314491
[TBL] [Abstract][Full Text] [Related]
9. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage.
Bagavant H; Deshmukh US; Gaskin F; Fu SM
Scand J Immunol; 2004; 60(1-2):52-63. PubMed ID: 15238073
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients.
Daamen AR; Wang H; Bachali P; Shen N; Kingsmore KM; Robl RD; Grammer AC; Fu SM; Lipsky PE
Front Immunol; 2023; 14():1147526. PubMed ID: 36936908
[TBL] [Abstract][Full Text] [Related]
11. Potential role of IFNα in adult lupus.
Rönnblom L
Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S3. PubMed ID: 20392290
[TBL] [Abstract][Full Text] [Related]
12. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.
Waters ST; Fu SM; Gaskin F; Deshmukh US; Sung SS; Kannapell CC; Tung KS; McEwen SB; McDuffie M
Clin Immunol; 2001 Sep; 100(3):372-83. PubMed ID: 11513551
[TBL] [Abstract][Full Text] [Related]
13. Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model.
Lee JY; Madany E; El Kadi N; Pandya S; Ng K; Yamashita M; Jefferies CA; Gibb DR
Front Immunol; 2020; 11():584254. PubMed ID: 33101313
[TBL] [Abstract][Full Text] [Related]
14. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.
Liu Z; Bethunaickan R; Huang W; Lodhi U; Solano I; Madaio MP; Davidson A
Arthritis Rheum; 2011 Jan; 63(1):219-29. PubMed ID: 20954185
[TBL] [Abstract][Full Text] [Related]
15. Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFN
Katewa A; Wang Y; Hackney JA; Huang T; Suto E; Ramamoorthi N; Austin CD; Bremer M; Chen JZ; Crawford JJ; Currie KS; Blomgren P; DeVoss J; DiPaolo JA; Hau J; Johnson A; Lesch J; DeForge LE; Lin Z; Liimatta M; Lubach JW; McVay S; Modrusan Z; Nguyen A; Poon C; Wang J; Liu L; Lee WP; Wong H; Young WB; Townsend MJ; Reif K
JCI Insight; 2017 Apr; 2(7):e90111. PubMed ID: 28405610
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune experimental orchitis and chronic glomerulonephritis with end stage renal disease are controlled by Cgnz1 for susceptibility to end organ damage.
Zhao Z; Qiao H; Ge Y; Kannapel CC; Sung SJ; Gaskin F; Tung KSK; Fu SM
Clin Immunol; 2021 Mar; 224():108675. PubMed ID: 33482358
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
[TBL] [Abstract][Full Text] [Related]
18. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of kidney disease in systemic lupus erythematosus.
Bagavant H; Fu SM
Curr Opin Rheumatol; 2009 Sep; 21(5):489-94. PubMed ID: 19584729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
